Replies to post #685 on Clinuvel Pharmaceuticals (CLVLY)

[contrarian bull]

If everything goes as expected, what might this mean to the company's bottom line? It seems everything is so hard to predict on top of all the legal and administrative uncertainty.

I’ve never been more sure about this stock than now. Nothing has changed fundamentally and we’re still on track for FDA approval in less than a month.

The first indication is only a foot in the door but still very valuable. In a few years we will probably be NASDAQ listes and have several other indications online as well as the cosmetic line and a pediatric lotion for EPP. We are only approaching the starting line.